Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-Label, Pharmacokinetic Study of the Penetration of Ceftobiprole Into Bone

NCT00771524 is registered in ClinicalTrials.gov with Basilea Pharmaceutica as lead sponsor.

NCT NCT00771524
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00771524 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-Label, Pharmacokinetic Study of the Penetration of Ceftobiprole Into Bone
Lead sponsor
Basilea Pharmaceutica
Phase
Phase 1
Overall status
Completed
Start date
April 30, 2009
Completion date
February 28, 2010
Enrollment
22 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

total hip replacement surgery